Quality Indicators in the Endoscopic Detection of Gastric Cancer

Overview

Journal DEN Open

Specialty Gastroenterology

Date 2023 Apr 13

PMID 37051139

Authors

Vikneswaran Namasivayam

Noriya Uedo

Affiliations

Soon will be listed here.

Abstract

Gastroscopy is the reference standard for the diagnosis of gastric cancer, but it is operator-dependent and associated with missed gastric cancer. The proliferation of gastroscopic examinations, increasingly for the screening and detection of subtle premalignant lesions, has motivated scrutiny of quality in gastroscopy. The concept of a high-quality endoscopic examination for the detection of superficial gastric neoplasia has been defined by expert guidelines to improve mucosal visualization, engender a systematic examination process and detect superficial neoplasia. This review discusses the evidence supporting the components of a high-quality diagnostic gastroscopic examination in relation to the detection of gastric cancer, and their potential role as procedural quality indicators to drive a structured improvement in clinically meaningful outcomes.

Citing Articles

Deep learning-based anatomical position recognition for gastroscopic examination.

Su X, Liu W, Jiang S, Gao X, Chu Y, Ma L Technol Health Care. 2024; 32(S1):39-48.

PMID: 38669495 PMC: 11191429. DOI: 10.3233/THC-248004.

Relationship between observation time and detection rate of focal lesions in Esophagogastroduodenoscopy: a single-center, retrospective study.

Dong L, Zhang X, Xuan Y, Xiong P, Ning Y, Zhang B BMC Gastroenterol. 2024; 24(1):75.

PMID: 38360548 PMC: 10870502. DOI: 10.1186/s12876-024-03157-3.

References

Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Arisawa T . Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc. 2009; 70(2):246-53. DOI: 10.1016/j.gie.2008.11.046. View

Kawamura T, Wada H, Sakiyama N, Ueda Y, Shirakawa A, Okada Y . Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017; 29(5):569-575. DOI: 10.1111/den.12804. View

Eom B, Lee J, Choi I, Kook M, Nam B, Ryu K . Pretreatment risk factors for multiple gastric cancer and missed lesions. J Surg Oncol. 2011; 105(8):813-7. DOI: 10.1002/jso.22124. View

Elvas L, Areia M, Brito D, Alves S, Saraiva S, Cadime A . Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial. Endoscopy. 2016; 49(2):139-145. DOI: 10.1055/s-0042-119034. View

Mabe K, Inoue K, Kamada T, Kato K, Kato M, Haruma K . Endoscopic screening for gastric cancer in Japan: Current status and future perspectives. Dig Endosc. 2021; 34(3):412-419. DOI: 10.1111/den.14063. View

Min J, Cha J, Cho Y, Kim J, Yoon S, Im J . Revision of Quality Indicators for the Endoscopy Quality Improvement Program of the National Cancer Screening Program in Korea. Clin Endosc. 2018; 51(3):239-252. PMC: 5997069. DOI: 10.5946/ce.2018.075. View

Marcos P, Brito-Goncalves G, Libanio D, Pita I, Castro R, Sa I . Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West?. Gut. 2020; 69(10):1762-1768. DOI: 10.1136/gutjnl-2019-320091. View

Gupta S, Li D, El Serag H, Davitkov P, Altayar O, Sultan S . AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. 2019; 158(3):693-702. PMC: 7340330. DOI: 10.1053/j.gastro.2019.12.003. View

Pimenta-Melo A, Monteiro-Soares M, Libanio D, Dinis-Ribeiro M . Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016; 28(9):1041-9. DOI: 10.1097/MEG.0000000000000657. View

10.

Kim G, Cho Y, Cha J, Lee S, Chung I . Efforts to increase image quality during endoscopy: The role of pronase. World J Gastrointest Endosc. 2016; 8(5):267-72. PMC: 4781907. DOI: 10.4253/wjge.v8.i5.267. View

11.

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

12.

Mabe K, Yao K, Nojima M, Tanuma T, Kato M . An educational intervention to improve the endoscopist's ability to correctly diagnose small gastric lesions using magnifying endoscopy with narrow-band imaging. Ann Gastroenterol. 2014; 27(2):149-155. PMC: 3982630. View

13.

Chang W, Yeh M, Hsu H, Chen H, Hu M . Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy. J Gastroenterol Hepatol. 2013; 29(4):769-74. DOI: 10.1111/jgh.12487. View

14.

Kim H, Cho E, Noh E, Choi S, Park S, Park M . Missed synchronous gastric neoplasm with endoscopic submucosal dissection for gastric neoplasm: experience in our hospital. Dig Endosc. 2013; 25(1):32-8. DOI: 10.1111/j.1443-1661.2012.01339.x. View

15.

Park J, Huo S, Lee H, Lee B, Song H, Choi M . Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy. Gastroenterology. 2017; 153(2):460-469.e1. DOI: 10.1053/j.gastro.2017.05.009. View

16.

Ang T, Pittayanon R, Lau J, Rerknimitr R, Ho S, Singh R . A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions. Eur J Gastroenterol Hepatol. 2015; 27(12):1473-8. DOI: 10.1097/MEG.0000000000000478. View

17.

Xie F, Zhang K, Li F, Ma G, Ni Y, Zhang W . Diagnostic accuracy of convolutional neural network-based endoscopic image analysis in diagnosing gastric cancer and predicting its invasion depth: a systematic review and meta-analysis. Gastrointest Endosc. 2022; 95(4):599-609.e7. DOI: 10.1016/j.gie.2021.12.021. View

18.

Hernanz N, Rodriguez de Santiago E, Prieto H, Jorge Turrion M, Barreiro Alonso E, Rodriguez Escaja C . Characteristics and consequences of missed gastric cancer: A multicentric cohort study. Dig Liver Dis. 2019; 51(6):894-900. DOI: 10.1016/j.dld.2019.02.006. View

19.

Monrroy H, Vargas J, Glasinovic E, Candia R, Azua E, Galvez C . Use of N-acetylcysteine plus simethicone to improve mucosal visibility during upper GI endoscopy: a double-blind, randomized controlled trial. Gastrointest Endosc. 2017; 87(4):986-993. DOI: 10.1016/j.gie.2017.10.005. View

20.

Park J, Kim S, Shin G, Choe Y, Cho H, Lim C . Implementation effect of institutional policy of EGD observation time on neoplasm detection. Gastrointest Endosc. 2020; 93(5):1152-1159. DOI: 10.1016/j.gie.2020.09.002. View